Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: J Proteome Res. 2018 Apr 25;17(5):1887–1897. doi: 10.1021/acs.jproteome.7b00901

Figure 7.

Figure 7.

Protective effects of MRL on TAA-induced liver injury. (A) ALT activity in plasma. (B) AST activity in plasma. (C) Hepatic index. (D) MDA content in plasma. (E) CAT activity in plasma. (F) Expression of Tnfa mRNA. ALT and AST activities in plasma increased significantly in TAA-treated group; treatment with MRL remarkably reduced the activities of the two amino transaminases. Oxidative stress mediated by TAA was inhibited by MRL; the expression of Tnfa was also decreased by MRL. *p < 0.05 as compared with control group, ***p < 0.001 as compared with control group, #p < 0.05 as compared with TAA-treated group, ###p < 0.001 as compared with TAA-treated group.